New updates have been reported about Optura.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Optura has secured a $17.5 million Series A round led by Salesforce Ventures, with Echo Health Ventures and existing backers Susa Ventures, Matrix Partners and HC9 Ventures participating, bringing total funding to more than $25 million. The company positions its ROAI platform as infrastructure for healthcare enterprises to assess and prioritize AI initiatives, moving the sector from experimental pilots to accountable, performance-based deployment.
Since its launch last year, Optura has attracted major health plans and provider groups, including Independence Blue Cross, Prime Therapeutics and Ardent Health, and now tracks more than $2 billion in AI projects on its system. The platform has identified over 250 AI use cases and is reporting $120 million in tracked value with a 700% return on AI investment for in-flight initiatives, as it maps fragmented data into a unified knowledge layer, ranks use cases by strategic fit and readiness, simulates financial returns before deployment and monitors realized impact through a single dashboard.
Investors say the funding reflects a shift in healthcare from AI experimentation to measurable outcomes, amid projections that the industry will spend over $18 billion on AI this year and growing concerns that most generative AI pilots are failing to deliver value. Optura plans to use the new capital to expand its AI capabilities, grow its platform teams and deepen large language model partnerships, betting that disciplined ROI measurement and governance will become a prerequisite for future AI spending decisions by health plans and providers.